通过血蛋白质组查来探索类风湿性关节炎潜在的新药标
Zhiqiang Ma1, Ran Chen2,3, Zibo Feng4
1Department of Cardiovascular Medicine, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
PLoS computational biology
|September 25, 2025
概括
这项研究确定了六种血蛋白,包括CILP2和TNFAIP3,作为类风湿性关节炎 (RA) 的潜在治疗标. 这些发现促进了对RA分子机制和药物开发的理解.
科学领域:
- * 遗传学和蛋白质组学
- * 风湿病学 风湿病学
- * 药物基因组学 药物基因组学
背景情况:
- * 循环中的蛋白质在类风湿性关节炎 (RA) 病变发生过程中至关重要.
- * 很少有RA相关的蛋白质被治疗向.
- *这项研究旨在发现RA治疗的新型蛋白质点.
研究的目的:
- * 为了确定类风湿性关节炎 (RA) 治疗的新型蛋白质点.
- * 探索血蛋白和RA之间的因果关系.
- * 验证RA的潜在治疗标和生物标志物.
主要方法:
- *对大规模GWAS数据进行了全面的全蛋白质组门德尔随机化 (MR),局部化和基于总结数据的MR (SMR) 分析.
- *验证涉及转录组数据分析,使用DsigDB识别药物标,以及分子模拟.
- *全现象关联研究 (Phe-WAS) 评估了潜在的副作用.
主要成果:
- *68种血蛋白显示出与RA有遗传预测的关联.
- *六种蛋白质 (FCRL3,SUGP1,TNFAIP3,EHBP1,HAPLN4,CILP2) 被确定为潜在的治疗标.
- *CILP2,TNFAIP3和EHBP1显示出潜在的RA生物标志物,在RA患者中观察到不同的表达模式.
结论:
- * 该研究阐明了血蛋白和RA之间的因果关系,增强了对分子的理解.
- *已识别的蛋白质为新的RA治疗开发提供了有前途的途径.
- *强调了针对这些蛋白质的潜在副作用,需要进一步调查.
更多相关视频
11:03A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model
Published on: October 30, 2019
8.9K
06:31Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
Published on: October 6, 2023
3.0K
相关概念视频
01:11Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
01:20The JAK-STAT Signaling Pathway
12.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.1K